The investments of the Government of Canada are tied not only to innovation and the vitality of the life sciences, but also to the health of our national economy. The pace of medical research must keep up with the aging of our population, the evolution of disease and treatment and the outcomes we value as a society. Baby boomers who are now in their 60s and 70s are likely to spend many more years of their lives working to maintain their health. There is an urgent need, both on the individual and socioeconomic level, for strategies to prevent illnesses associated with aging or lifestyle. Diseases such as Alzheimer’s, cancer, ALS, diabetes and heart disease threaten to overwhelm our healthcare system in just a matter of years with enormous costs of care if we don’t find ways to prevent, treat – or even cure – them.
At Johnson & Johnson, our vision is to positively impact human health through innovation. Every year, we invest billions of dollars in research and development across our pharmaceutical, consumer and medical device companies. As part of our external R&D engine, we help entrepreneurs and scientists around the world, and in Canada, to realize their dreams of creating healthcare solutions that improve lives. Internally, our teams of scientists work tirelessly to accelerate the translation of scientific discoveries into meaningful treatments for patients in need. Much of our work, and that of scientists across the industry, would not be possible without the constant progression of the understanding of underlying disease biology – precisely the type of research funded by the Government of Canada.